R. Bendayan et al., INTERACTION OF 3'-AZIDO-3'-DEOXYTHYMIDINE WITH THE ORGANIC-BASE TRANSPORTER IN A CULTURED RENAL EPITHELIUM, Pharmacotherapy, 15(3), 1995, pp. 338-344
In humans and various animal species, 3'-azido-3'-deoxythymidine (AZT)
is in part eliminated by the kidneys, where it undergoes significant
tubular secretion. The goal of this project was to develop, in a conti
nuous renal epithelial cell line (LLCPK(1)), a model of AZT transport
in which mechanisms of drug interactions could be investigated. Transp
ort properties of H-3-AZT were studied in LLCPK(1) cells grown as mono
layers on permeable filters. This system provides access to the basola
teral and apical surfaces of the epithelium and allows the determinati
on of substrate transepithelial nux from the basolateral side to the a
pical side (B --> A/secretory direction) and apical to basolateral sid
e (A --> B/reabsorptive direction). The B --> A flux of AZT was signif
icantly greater than B --> A flux of mannitol (a nontransported substr
ate) and was temperature dependent (37 degrees C >> 4 degrees C). The
AZT A --> B flux was significantly smaller than the B -->, A flux, ind
icating that the drug is predominantly secreted in this renal epitheli
um. The B --> A flux was significantly inhibited by the organic bases
cimetidine, quinine, quinidine, and trimethoprim. Log concentration do
se studies indicate that quinine is a weak inhibitor (IC50 = 9.61 mM)
of AZT B --> A flux, and that AZT is a moderate inhibitor (IC50 = 0.69
mM) of the organic base cimetidine. These results suggest that AZT ma
y share the organic base transporter in the renal epithelium, and that
this model can be used successfully to study transport properties and
renal drug-drug interactions of AZT.